Adoptive immunotherapy for cancer: harnessing the T cell response - Wikidata - awgldk - TriplyDB

Adoptive immunotherapy for cancer: harnessing the T cell response

Adoptive immunotherapy for cancer: harnessing the T cell response

http://www.wikidata.org/entity/Q28262548

about

Oncolytic viruses as therapeutic cancer vaccines Robust tumor immunity to melanoma mediated by interleukin-9-producing T cells A Perspective of Immunotherapy for Prostate Cancer Engineered Swine Models of Cancer Breaking Free of Control: How Conventional T Cells Overcome Regulatory T Cell Suppression.CAR models: next-generation CAR modifications for enhanced T-cell function Chimeric antigen receptor T-cell therapy for solid tumors Action and Traction: Cytoskeletal Control of Receptor Triggering at the Immunological Synapse Updates in Therapy for Advanced Melanoma Blood transcriptomics and metabolomics for personalized medicine Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Lymphoma Immunotherapy: Current Status CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Trial Watch: Adoptive cell transfer for oncological indications Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models Melanoma: From Incurable Beast to a Curable Bet. The Success of Immunotherapy Control of CD8 T-Cell Infiltration into Tumors by Vasculature and Microenvironment T cell metabolism drives immunity Synthetic therapeutic gene circuits in mammalian cells T lymphocytes targeting native receptors The promise of γδ T cells and the γδ T cell receptor for cancer immunotherapy Interleukin 12: still a promising candidate for tumor immunotherapy?Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications Adoptive T Cell Therapy Targeting CD1 and MR1 Sorting through subsets: which T-cell populations mediate highly effective adoptive immunotherapy?Linking form to function: Biophysical aspects of artificial antigen presenting cell design Novel immunotherapies for hematologic malignancies Adoptive T-cell therapy for Leukemia Using gene therapy to manipulate the immune system in the fight against B-cell leukemias Heterogeneity in immune responses: from populations to single cells Immunotargeting of cancer stem cells Update on the challenges and recent advances in cancer immunotherapy Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy CD4 T-cell immunotherapy for chronic viral infections and cancer An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma Regulatory T-cell therapy in transplantation: moving to the clinic Targeting the tumor vasculature to enhance T cell activity Lineage relationship of effector and memory T cells

P2860

Q21245758-1626D713-299D-444D-A105-5A75C857CC3B Q24601213-DAFEC022-42BC-4EE7-A276-5A5C06532365 Q26741277-3DA7651A-7BF2-4140-9B64-F8883B2BADBF Q26744575-54999734-F3D6-4C6E-A39D-A306257A4036 Q26744624-A3F63D00-52C6-40EB-88CB-723B4EABC9E5 Q26745600-D4F49E10-161F-46EC-B9FE-07EFAB6DF606 Q26750908-EAC73688-EAD5-445E-8F63-CE66419CBBA7 Q26751049-1054ECA6-D66F-4EE7-980B-7BB444067BF3 Q26771119-BD437FE6-7010-4182-8F7D-A5D35127D459 Q26772073-283AAD95-CE0C-4BE6-B002-C237E529631E Q26774669-0DC1C5DE-CEDA-4350-8C32-B2CBBBDE593A Q26781215-9A345BB7-30BE-4214-8D7E-8FDD2F5A495F Q26782902-7AA88774-404D-48B4-82DA-8825EB1041CA Q26783433-9C6800D8-7D6A-40D4-B9A6-0024198EACEC Q26785545-406D7F6A-F078-42C4-8074-C57D18F3B437 Q26797285-CE8EFF14-6A48-4234-A93A-82AE9C98BD09 Q26798404-76A5E6E2-BF44-4D9D-9EC7-F3D07E47051C Q26799117-B6324151-A5DD-42D8-A171-6A2119C8EABD Q26799575-80729190-5F2F-4B83-B9B9-D641B67F6014 Q26826954-3D13A862-1A91-4D7B-B6D7-B65550DCAE80 Q26853345-A57FD03E-0DE6-43BE-8697-E9E365CA6B4A Q26859775-63B7C278-DB62-4067-BBAB-DF46AD123B1E Q26861559-81B1D04B-3ECB-41D9-B81C-077EE8F53444 Q26991991-F24D55CA-CE95-4A35-AAFB-414640B8B5FA Q26996518-EBF25BFD-8E51-440B-920E-60DA9B9CACFB Q26998503-25BF9F83-4981-4F65-A44A-57F11BC9867C Q27002575-168F44E0-8080-40ED-AFE7-5CE3486C8605 Q27002652-4F1DA73B-E0D0-4461-810B-E197D9E79395 Q27004436-02DD7CF4-1963-4E11-838A-CF4245330A1B Q27006934-827092CC-EC3E-48E4-AE19-AF33EBE85B26 Q27011297-36CE23E7-B554-4CE9-8AD0-012CCF4A61BA Q27013828-302B9E13-8E89-46EC-AE5C-3BCF4E425EEE Q27014031-E991C9C4-8453-472E-B42D-74822954AD0E Q27014693-96E4AD57-BC63-4D81-8F8F-1016F13E8086 Q27021570-18ECB2D0-9254-4764-838A-DDE225FAE5F6 Q27022957-164C69A1-BBA9-4530-A33D-C8504B1CA46E Q27024830-F9E5367D-8E3D-48C4-B128-F603516B94F4 Q27025869-A8E7B701-88BC-4212-A685-816ECC3F96D0 Q27026329-2D3A7619-A1DD-4D51-B499-109A2CC10300 Q27026665-6AE61BCD-B584-445F-9E24-423BFC9AD71E

P2860

Adoptive immunotherapy for cancer: harnessing the T cell response

http://www.wikidata.org/entity/Q28262548

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Adoptive immunotherapy for cancer: harnessing the T cell response

@ast

Adoptive immunotherapy for cancer: harnessing the T cell response

@en

Adoptive immunotherapy for cancer: harnessing the T cell response

@nl

type

label

Adoptive immunotherapy for cancer: harnessing the T cell response

@ast

Adoptive immunotherapy for cancer: harnessing the T cell response

@en

Adoptive immunotherapy for cancer: harnessing the T cell response

@nl

prefLabel

Adoptive immunotherapy for cancer: harnessing the T cell response

@ast

Adoptive immunotherapy for cancer: harnessing the T cell response

@en

Adoptive immunotherapy for cancer: harnessing the T cell response

@nl

P1433

Q28262548-1EAACA86-02B3-4D54-A2C4-CED553DA88B5

P1476

Q28262548-AC057194-08CA-4630-89C5-4D12E189DD7C

P2093

Q28262548-1644AD8E-B2CC-4A91-869A-FFBBCC6AB0FC

Q28262548-9126109D-4B48-4DDD-AA1C-9D14678FD787

P304

Q28262548-62B4293A-5432-431A-A289-72D8168DF480

P31

Q28262548-1931D41D-AE3E-4E70-A3BF-B77D61C4B369

P3181

Q28262548-29AE3E59-497F-4E41-A687-F7DF284EACC1

P356

Q28262548-7C8CC794-D931-40BA-BCBC-97EBE1EBAF5A

P407

Q28262548-D3887298-7C89-46F5-BDC2-C942F2CBECBA

P433

Q28262548-96373C1F-526F-4D4F-A063-4B3ED5CEC701

P478

Q28262548-893B9870-CA6C-472B-BAC4-96AA230FB5FD

P50

Q28262548-2B544672-36B4-403A-9A10-E1402E07B5DA

P577

Q28262548-018C3E4C-D41A-4E9E-B702-F320E81FF00D

P5875

Q28262548-EF5B5566-4361-456F-8FAE-3824F7604A37

P698

Q28262548-4470DAF4-6864-48A1-AD3C-A37DC7902756

P921

Q28262548-A77BC04B-273F-420B-B2F7-69716D46F25D

P932

Q28262548-65C19A22-E160-4C32-A6E7-69C92730A937

P3181

P356

P1433

Nature Reviews Immunology

P1476

Adoptive immunotherapy for cancer: harnessing the T cell response

@en

P2093

Mark E Dudley

http://www.w3.org/2001/XMLSchema#string

Steven A Rosenberg

http://www.w3.org/2001/XMLSchema#string

P304

269-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

42260

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NRI3191

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

12

http://www.w3.org/2001/XMLSchema#string

P50

Nicholas P. Restifo

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221904481

http://www.w3.org/2001/XMLSchema#string

P698

22437939

http://www.w3.org/2001/XMLSchema#string

P921

P932

6292222

http://www.w3.org/2001/XMLSchema#string